Systematic review of the efficacy, effectiveness and safety of newer and enhanced seasonal influenza vaccines
Overall the evidence base for the efficacy and effectiveness of newer and enhanced influenza vaccines appears limited at present, with a number of potentially relevant studies identified as ongoing.
Video on vaccination: Effective worldwide vaccination campaigns
Effective worldwide vaccination campaigns have dramatically reduced the number of deadly infections. Watch our video (turn on subtitles in your language!) and learn more about the vaccination success stories on the fight with smallpox, polio, tetanus and measles.
Video on vaccination: Fighting tetanus
Tetanus is transmitted by bacteria living in soil, animal saliva and manure which can enter the body through minor wounds on the skin. Today, a widely used vaccine protects against tetanus.
Video on vaccination: Fighting measles
Measles is one of the world’s most contagious diseases. The measles virus was identified in 1954 and a vaccine was introduced in 1963. Between 2000 and 2018, global measles deaths decreased by 73%, and 23 million deaths were prevented thanks to vaccination. But the fight is still ongoing. Learn more about it in our video (turn on subtitles in your language)!
Video on vaccination: Eliminating smallpox
Smallpox was once a common, deadly disease, that killed a third of those who contracted it. 200 years ago, it was discovered that vaccination could prevent smallpox. Learn more about the fight against smallpox in our video (turn on subtitles in your language)!
Video on vaccination: Fighting polio
Polio is an infectious disease mostly contracted by children. One in two hundred people develop incurable paralysis after infection. In 1955, a vaccine was invented and was introduced on a wide scale. Thanks to global efforts, polio was eliminated from the Western Hemisphere by 1994, and has greatly decreased worldwide.
Children Immunization App (CIMA) among Syrian refugees in Zaatari Camp, Jordan: Protocol for a cluster randomized controlled pilot trial intervention study
Khader, Y.S., Laflamme, L., Schmid, D., El-Halabi, S., Abu Khdair, M., Sengoelge, M., Atkins, S., Tahtamouni, M., Derrough, T., El-Khatib, Z.
Why we need more collaboration in Europe to enhance post-marketing surveillance of vaccines
Sturkenboom M, Bahri P, Chiucchiuini A, Grove Krause T, HahnÃ© S, Khromava A, Kokki M, Kramarz P, Kurz X, Larson HJ, de Lusignan S, Mahy P, Torcel-Pagnon L, Titievsky L, Bauchau V; ADVANCE consortium..
Hepatitis B and C among healthcare workers and patient groups at increased risk of iatrogenic transmission in the European Union/European Economic Area
Tavoschi, L., Mason, L., Petriti, U., Bunge, E., Veldhuijzen, I., Duffell, E.
Hepatitis b and c prevalence and incidence in key population groups with multiple risk factors in the EU/ EEA: A systematic review
Mason, L.M.K., Duffell, E., Veldhuijzen, I.K., Petriti, U., Bunge, E.M., Tavoschi, L.